Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival
被引:37
作者:
Barton, C. A.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Barton, C. A.
[1
]
Gloss, B. S.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Gloss, B. S.
[1
]
Qu, W.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Qu, W.
[1
]
Statham, A. L.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Statham, A. L.
[1
]
Hacker, N. F.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Royal Hosp Women, Gynaecol Canc Ctr, Randwick, NSW 2031, Australia
Univ NSW, Fac Med, Sydney, NSW 2031, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Hacker, N. F.
[1
,2
,3
]
Sutherland, R. L.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Univ NSW, Fac Med, Sydney, NSW 2031, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Sutherland, R. L.
[1
,3
]
Clark, S. J.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Univ NSW, Fac Med, Sydney, NSW 2031, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Clark, S. J.
[1
,3
]
O'Brien, P. M.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
Univ NSW, Fac Med, Sydney, NSW 2031, AustraliaSt Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
O'Brien, P. M.
[1
,3
]
机构:
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Royal Hosp Women, Gynaecol Canc Ctr, Randwick, NSW 2031, Australia
[3] Univ NSW, Fac Med, Sydney, NSW 2031, Australia
BACKGROUND: Collagen and calcium-binding EGF domains 1 (CCBE1) is an uncharacterised gene that has down-regulated expression in breast cancer. As CCBE1 maps to 18q21.32, a region frequently exhibiting loss of heterozygosity in ovarian cancer, the aim of this study was to determine the expression and function of CCBE1 in ovarian cancer. METHODS: Expression and methylation patterns of CCBE1 were determined in ovarian cancer cell lines and primary tumours. CCBE1 contains collagen repeats and an aspartic acid/asparagine hydroxylation/EGF-like domain, suggesting a function in extracellular matrix remodelling and migration, which was determined using small-interfering RNA (siRNA)-mediated knockdown and over-expression of CCBE1 in cell lines. RESULTS: CCBE1 is expressed in normal ovary, but is reduced in ovarian cancer cell lines and primary carcinomas. Pharmacological demethylation/deacetylation in ovarian cancer cell lines re-induced CCBE1 expression, indicating that epigenetic mechanisms contribute to its silencing in cancer. CCBE1 promoter hypermethylation was detected in 6/11 (55%) ovarian cancer cell lines and 38/81 (41%) ovarian carcinomas. siRNA-mediated knockdown of CCBE1 in ovarian cancer cell lines enhanced their migration; conversely, re-expression of CCBE1 reduced migration and survival. Hence, loss of CCBE1 expression may promote ovarian carcinogenesis by enhancing migration and cell survival. CONCLUSIONS: These data suggest that CCBE1 is a new candidate tumour suppressor in ovarian cancer. British Journal of Cancer (2010) 102, 87-96. doi:10.1038/sj.bjc.6605429 www.bjcancer.com Published online 24 November 2009 (C) 2010 Cancer Research UK